Cleared Traditional

K912293 - REMOVE LABELING RESTRICT FROM GUIDE WIRES

K912293 is an FDA 510(k) clearance for REMOVE LABELING RESTRICT FROM GUIDE WIRES, manufactured by Target Therapeutics. The device is a Class 2 Cardiovascular device with product code DQX cleared through the Traditional 510(k) pathway after a 196-day FDA review.

K912293 · Target Therapeutics · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1991
Decision
196d
Days
Class 2
Risk

K912293 is an FDA 510(k) clearance for the REMOVE LABELING RESTRICT FROM GUIDE WIRES. Classified as Wire, Guide, Catheter (product code DQX), Class II - Special Controls.

Submitted by Target Therapeutics (San Jose, US). The FDA issued a Cleared decision on December 5, 1991 after a review of 196 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1330 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Target Therapeutics devices

FDA 510(k) Submission Details - K912293

510(k) Number K912293 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 23, 1991
Decision Date December 05, 1991
Days to Decision 196 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
71d slower than avg
Panel avg: 125d · This submission: 196d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQX Device Classification - Class 2, Special Controls

Product Code DQX Wire, Guide, Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQX Wire, Guide, Catheter

All 690
Devices cleared under the same product code (DQX) and FDA review panel - the closest regulatory comparables to K912293.
010 HI-TOR INTER/STAND GUIDWIRE PRESHAPE TIP/MODIF
K914828 · Advanced Cardiovascular Systems, Inc. · Jan 1992
CORDIS CINCH(R) STEERABLE GUIDEWIRE EXT W/SLX COAT
K914863 · Cordis Corp. · Dec 1991
ONTRAC
K914138 · Lake Region Mfg., Inc. · Dec 1991
0.016 GUIDE WIRE FOR NEUROLOGICAL ENDOSCOPE
K913074 · Terumo Medical Corp. · Nov 1991
.014 HI-TORQUE FLOPPY PATHFINDER GUIDE WIRE
K913631 · Advanced Cardiovascular Systems, Inc. · Oct 1991
.010 HI-TORQUE PLUS(TM) GUIDE WIRE
K913328 · Advanced Cardiovascular Systems, Inc. · Oct 1991